BioVantra
Client Portal Request Information →
Services / IPCT

Integrated Prostate
Cytomolecular Testing.

A prostate-focused diagnostic service that brings prostate FNA cytology, TMPRSS2-ERG FISH, whole-gland sector mapping, and a Genetic Complexity Score (GCS) together into a single structured report. The approach is designed to provide a broader, sector-based perspective across the gland — and to complement MRI, core needle biopsy, and other clinical information.

Request Information → Back to Services
Inputs
FNA · FISH · GCS
Perspective
Whole-gland, sector-based
Delivery
Structured integrated report
01 · What the service includes

Four components,
one integrated report.

IPCT combines morphologic, molecular, spatial, and biologic information into a single structured interpretation. Together, the four components are designed to support a broader, sector-based read of the gland rather than a view limited to a single sampled focus.

A

Prostate FNA cytology

Fine-needle aspiration provides cellular, morphologic assessment of sampled tissue. Cytologic review supports characterization of each sector and forms the morphologic foundation of the integrated interpretation.

B

TMPRSS2-ERG FISH

Fluorescence in situ hybridization for the TMPRSS2-ERG rearrangement adds complementary molecular information to morphologic review, contributing biologic context that cytology alone does not provide.

C

Whole-gland sector mapping

Multi-sector sampling across the prostate supports a spatial, whole-gland perspective rather than a view centered on a single tumor focus. Sectors may be reported as concordant, discordant, indeterminate, or negative, and may help characterize focality and laterality across the gland.

D

Integrated interpretation with GCS

Morphologic, molecular, and spatial findings are reviewed together and delivered as a structured synoptic report that includes a Genetic Complexity Score (GCS) to add biologic context and support multidisciplinary communication.

02 · Clinical relevance

A broader view of the
gland, in one place.

The integrated format is designed to complement MRI, histopathology, core needle biopsy, and other clinical data. It does not replace them. Its value is in how morphologic, molecular, and spatial information are organized together to support a broader, sector-based view of the gland during diagnostic and treatment conversations.

  • A

    Correlation with MRI and clinical findings

    Sector-level results are structured so they can be read alongside MRI, PSA trends, and prior histopathology, supporting correlation across imaging and tissue-based information.

  • B

    Beyond the dominant lesion

    Whole-gland sampling may identify findings outside the dominant lesion, including concordant, discordant, indeterminate, and negative sectors that can inform how the case is interpreted as a whole.

  • C

    Support for biopsy and treatment planning

    Structured, sector-based reporting may assist biopsy planning, treatment planning, focality and laterality assessment, and multidisciplinary interpretation by making the spatial distribution of findings easier to reference across the care team.

  • D

    Complements, does not replace

    IPCT is intended to complement core needle biopsy and other prostate cancer tests, contributing integrated morphologic, molecular, and spatial information to multidisciplinary review rather than substituting for existing workflows.

Clinical resources

Download physician-facing reference material related to Integrated Prostate Cytomolecular Testing.

PDF 01

Integrated Prostate Cytomolecular Testing Overview

A concise physician-facing overview of the service, report structure, and clinical value.

Open PDF →
PDF 02

Curated Clinical Case & Sample Report

A physician-facing case companion followed by a sample Integrated Prostate Cytomolecular Report.

Open PDF →
Connect with BioVantra

Talk to us about integrated prostate diagnostics.

We work with urology practices and clinical teams involved in prostate cancer diagnosis and treatment. Share a little about your setting and a member of our team will follow up to discuss how IPCT may fit into your workflow.

Request Information → Contact our team
Existing client? Access diagnostic reports and case history through the Client Portal
Emailcontact@biovantra.com
Phone(352) 861-2296
Fax(352) 671-2737
Address9401 SW Highway 200
STE 502
Ocala, FL 34481-9650